tiprankstipranks
Inspire Medical Systems (DE:2DR)
FRANKFURT:2DR
Germany Market
2DR
Inspire Medical Systems
RESEARCH TOOLSreports

Inspire Medical Systems (2DR) Ratios

12 Followers

Inspire Medical Systems Ratios

DE:2DR's free cash flow for Q2 2026 was $0.85. For the 2026 fiscal year, DE:2DR's free cash flow was decreased by $ and operating cash flow was
gt;-0.01. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 8.55 6.08 7.13 7.60 8.66
Quick Ratio
 6.16 4.56 6.22 7.17 8.47
Cash Ratio
 1.79 1.09 1.70 2.38 7.22
Solvency Ratio
 1.52 1.26 0.51 -0.18 -0.62
Operating Cash Flow Ratio
 2.21 1.22 1.47 0.32 0.19
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 508.26M$ 457.50M$ 512.12M$ 489.44M$ 461.16M
Leverage Ratios
Debt-to-Assets Ratio
 0.03 0.04 0.04 0.04 0.02
Debt-to-Equity Ratio
 0.04 0.04 0.05 0.04 0.02
Debt-to-Capital Ratio
 0.03 0.04 0.04 0.04 0.02
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.12 1.16 1.17 1.18 1.14
Debt Service Coverage Ratio
 1.12K 1.16K 2.73K 0.00 -24.65
Interest Coverage Ratio
 406.94 371.93 1.64K 0.00 -28.38
Debt to Market Cap
 0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
 1.01 1.10 1.07 0.85 0.38
Net Debt to EBITDA
 -1.19 -0.91 -1.82 9.42 10.62
Profitability Margins
Gross Profit Margin
86.13%85.39%84.68%84.54%83.79%
EBIT Margin
7.33%7.22%7.28%-3.19%-10.44%
EBITDA Margin
9.25%8.75%8.10%-2.73%-9.99%
Operating Profit Margin
6.02%5.59%4.49%-6.45%-11.67%
Pretax Profit Margin
7.72%7.20%7.28%-3.19%-10.85%
Net Profit Margin
15.03%15.95%6.67%-3.39%-11.00%
Continuous Operations Profit Margin
15.03%15.95%6.67%-3.39%-11.00%
Net Income Per EBT
194.64%221.35%91.54%106.26%101.38%
EBT Per EBIT
128.19%128.93%162.00%49.43%93.02%
Return on Assets (ROA)
14.58%16.03%6.62%-3.13%-7.95%
Return on Equity (ROE)
17.62%18.62%7.76%-3.69%-9.05%
Return on Capital Employed (ROCE)
6.33%6.28%5.01%-6.73%-9.45%
Return on Invested Capital (ROIC)
6.33%6.26%4.58%-6.73%-9.42%
Return on Tangible Assets
14.58%16.03%6.62%-3.13%-7.95%
Earnings Yield
7.54%5.37%0.97%-0.35%-0.63%
Efficiency Ratios
Receivables Turnover
 8.70 7.62 8.63 6.95 6.66
Payables Turnover
 4.60 3.64 3.18 2.49 2.46
Inventory Turnover
 0.73 0.92 1.54 2.85 5.56
Fixed Asset Turnover
 7.08 7.51 8.43 9.97 16.90
Asset Turnover
 0.97 1.01 0.99 0.92 0.72
Working Capital Turnover Ratio
 1.77 1.77 1.52 1.27 1.17
Cash Conversion Cycle
 461.77 345.79 165.27 33.79 -27.80
Days of Sales Outstanding
 41.97 47.90 42.31 52.51 54.79
Days of Inventory Outstanding
 499.17 398.06 237.78 128.07 65.62
Days of Payables Outstanding
 79.37 100.18 114.82 146.79 148.21
Operating Cycle
 541.14 445.97 280.09 180.57 120.41
Cash Flow Ratios
Operating Cash Flow Per Share
 5.45 3.98 4.38 0.84 0.41
Free Cash Flow Per Share
 4.06 2.67 3.06 0.03 0.09
CapEx Per Share
 1.39 1.31 1.31 0.81 0.32
Free Cash Flow to Operating Cash Flow
 0.75 0.67 0.70 0.04 0.21
Dividend Paid and CapEx Coverage Ratio
 3.93 3.04 3.33 1.04 1.27
Capital Expenditure Coverage Ratio
 3.93 3.04 3.33 1.04 1.27
Operating Cash Flow Coverage Ratio
 5.40 3.64 4.10 0.99 1.30
Operating Cash Flow to Sales Ratio
 0.17 0.13 0.16 0.04 0.03
Free Cash Flow Yield
6.52%2.90%1.65%0.02%0.03%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 13.33 18.63 102.99 -281.80 -157.54
Price-to-Sales (P/S) Ratio
 2.00 2.97 6.87 9.54 17.34
Price-to-Book (P/B) Ratio
 2.17 3.47 8.00 10.41 14.26
Price-to-Free Cash Flow (P/FCF) Ratio
 15.34 34.52 60.55 5.82K 2.86K
Price-to-Operating Cash Flow Ratio
 11.41 23.16 42.36 241.79 611.18
Price-to-Earnings Growth (PEG) Ratio
 0.08 0.11 -0.29 5.12 -40.44
Price-to-Fair Value
 2.17 3.47 8.00 10.41 14.26
Enterprise Value Multiple
 20.43 33.04 83.03 -339.99 -162.96
Enterprise Value
 1.70B 2.64B 5.40B 5.80B 6.64B
EV to EBITDA
 20.43 33.04 83.03 -339.99 -162.96
EV to Sales
 1.89 2.89 6.73 9.28 16.28
EV to Free Cash Flow
 14.50 33.59 59.25 5.66K 2.68K
EV to Operating Cash Flow
 10.81 22.53 41.45 235.28 573.77
Tangible Book Value Per Share
 28.63 26.60 23.17 19.54 17.67
Shareholders’ Equity Per Share
 28.63 26.60 23.17 19.54 17.67
Tax and Other Ratios
Effective Tax Rate
 -0.95 -1.21 0.08 -0.06 -0.01
Revenue Per Share
 31.17 31.05 26.97 21.32 14.53
Net Income Per Share
 4.68 4.95 1.80 -0.72 -1.60
Tax Burden
 1.95 2.21 0.92 1.06 1.01
Interest Burden
 1.05 1.00 1.00 1.00 1.04
Research & Development to Revenue
 0.11 0.11 0.14 0.19 0.17
SG&A to Revenue
 0.69 0.68 0.66 0.00 0.00
Stock-Based Compensation to Revenue
 0.13 0.14 0.14 0.13 0.13
Income Quality
 1.16 0.80 2.43 -1.17 -0.26
Currency in USD